Schetelig J - Search Results

1

Kinetics of stem cell engraftment and clearance of leukaemia cells after allogeneic stem cell transplantation with reduced intensity conditioning in chronic myeloid leukaemia.

Kreuzer KA, Schmidt CA, Schetelig J, Held TK, Thiede C, Ehninger G, Siegert W. Kreuzer KA, et al. Among authors: schetelig j. Eur J Haematol. 2002 Jul;69(1):7-10. doi: 10.1034/j.1600-0609.2002.01761.x. Eur J Haematol. 2002. PMID: 12270056

2

Complete remission of primary high-grade B-cell gastric lymphoma after cure of Helicobacter pylori infection.

Morgner A, Miehlke S, Fischbach W, Schmitt W, Müller-Hermelink H, Greiner A, Thiede C, Schetelig J, Neubauer A, Stolte M, Ehninger G, Bayerdörffer E. Morgner A, et al. Among authors: schetelig j. J Clin Oncol. 2001 Apr 1;19(7):2041-8. doi: 10.1200/JCO.2001.19.7.2041. J Clin Oncol. 2001. PMID: 11283137

3

A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome.

Kröger N, Schetelig J, Zabelina T, Krüger W, Renges H, Stute N, Schrum J, Kabisch H, Siegert W, Zander AR. Kröger N, et al. Among authors: schetelig j. Bone Marrow Transplant. 2001 Oct;28(7):643-7. doi: 10.1038/sj.bmt.1703215. Bone Marrow Transplant. 2001. PMID: 11704786

4

Dose-reduced conditioning for allografting in 44 patients with chronic myeloid leukaemia: a retrospective analysis.

Bornhäuser M, Kiehl M, Siegert W, Schetelig J, Hertenstein B, Martin H, Schwerdtfeger R, Sayer HG, Runde V, Kröger N, Theuser C, Ehninger G; Cooperative German Transplant Study Group. Bornhäuser M, et al. Among authors: schetelig j. Br J Haematol. 2001 Oct;115(1):119-24. doi: 10.1046/j.1365-2141.2001.03074.x. Br J Haematol. 2001. PMID: 11722421 Free article.

5

Allogeneic transplantation after reduced conditioning in high risk patients is complicated by a high incidence of acute and chronic graft-versus-host disease.

Schetelig J, Kröger N, Held TK, Thiede C, Krusch A, Zabelina T, Dubiel M, Rick O, Bornhäuser M, Ehninger G, Zander AR, Siegert W. Schetelig J, et al. Haematologica. 2002 Mar;87(3):299-305. Haematologica. 2002. PMID: 11869943

6

Reduced non-relapse mortality after reduced intensity conditioning in advanced chronic lymphocytic leukemia.

Schetelig J, Thiede C, Bornhäuser M, Schwerdtfeger R, Kiehl M, Beyer J, Kröger N, Hensel M, Scheffold C, Ho AD, Kienast J, Neubauer A, Zander AR, Fauser AA, Ehninger G, Siegert W. Schetelig J, et al. Ann Hematol. 2002;81 Suppl 2:S47-8. Ann Hematol. 2002. PMID: 12611075

7

Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia: disease status by marrow blasts is the strongest prognostic factor.

Sayer HG, Kröger M, Beyer J, Kiehl M, Klein SA, Schaefer-Eckart K, Schwerdtfeger R, Siegert W, Runde V, Theuser C, Martin H, Schetelig J, Beelen DW, Fauser A, Kienast J, Höffken K, Ehninger G, Bornhäuser M; Cooperative German Transplant Study Group. Sayer HG, et al. Among authors: schetelig j. Bone Marrow Transplant. 2003 Jun;31(12):1089-95. doi: 10.1038/sj.bmt.1704062. Bone Marrow Transplant. 2003. PMID: 12796788

8

Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: the Cooperative German Transplant Study Group.

Schetelig J, Thiede C, Bornhauser M, Schwerdtfeger R, Kiehl M, Beyer J, Sayer HG, Kroger N, Hensel M, Scheffold C, Held TK, Hoffken K, Ho AD, Kienast J, Neubauer A, Zander AR, Fauser AA, Ehninger G, Siegert W; Cooperative German Transplant Study Group. Schetelig J, et al. J Clin Oncol. 2003 Jul 15;21(14):2747-53. doi: 10.1200/JCO.2003.12.011. J Clin Oncol. 2003. PMID: 12860954

9

Cytomegalovirus infections in allogeneic stem cell recipients after reduced-intensity or myeloablative conditioning assessed by quantitative PCR and pp65-antigenemia.

Schetelig J, Oswald O, Steuer N, Radonic A, Thulke S, Held TK, Oertel J, Nitsche A, Siegert W. Schetelig J, et al. Bone Marrow Transplant. 2003 Oct;32(7):695-701. doi: 10.1038/sj.bmt.1704164. Bone Marrow Transplant. 2003. PMID: 13130317 Clinical Trial.

10

Quantitative real-time PCR compared with pp65 antigen detection for cytomegalovirus (CMV) in 1122 blood specimens from 77 patients after allogeneic stem cell transplantation: which test better predicts CMV disease development?

Nitsche A, Oswald O, Steuer N, Schetelig J, Radonić A, Thulke S, Siegert W. Nitsche A, et al. Among authors: schetelig j. Clin Chem. 2003 Oct;49(10):1683-5. doi: 10.1373/49.10.1683. Clin Chem. 2003. PMID: 14500600 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

244 results

Search Page

Filters